[Results of a multicenter, phase-II clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy].

Autor:	Garin AM, Gorbunova VA, Bychkov MB, Mindra NV, Stenina MB, Topchieva SV, Treshchalina EM, Chitiia LV, Sdvizhkov AM, Borisov VI, Gurov SN, Gershanovich ML, Makhnova EV, Nebol'sin VE
Jazyk:	ruština
Zdroj:	Voprosy onkologii [Vopr Onkol] 2004; Vol. 50 (2), pp. 184-8.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu